speaker photo

David Loughton CBE

Chief Executive - The Royal Wolverhampton NHS Trust

David is the longest-serving Chief Executive’s in the NHS.  His first Chief Executive appointment was at the University Hospitals Coventry and Warwickshire NHS Trust in 1986 where he successfully led the organisation through two hospital mergers, developed with Warwick University a new medical school, and reached financial closure of a new £400m hospital.

David commenced as Chief Executive of The Royal Wolverhampton NHS Trust (RWT) in 2004.   He has led the organisation from one of the most financially challenged in the NHS to being financially sound whilst at the same time gaining a national and international reputation for improving patient safety and experience.  Under David’s leadership, the Trust has expanded from 4,200 employees to 10,600.

The Trust host’s the National Institute for Health Research (NIHR), the Clinical Research Network for the whole of the West Midlands, which is the largest network in the UK and currently ranks number one out of fifteen networks for performance

David worked with the Trust’s Special Administrator Team at Mid Staffordshire Foundation Trust to desegregate and acquire a range of services from the former Mid Staffordshire Foundation Trust.

RWT is almost unique in being an end of end provider of tertiary care, secondary care, community care, primary care, and public health.  We are now progressing with partner organisations to become an integrated care partnership.

Most recently David has taken on the role of Chair of the West Midlands Cancer Alliance.  The Alliance’s programme of work includes ensuring local plans are aligned and support STPs and transformation across the West Midlands.  It will act as the decision-making body in relation to the planning and delivery of the Cancer Taskforce strategy.

In light of workforce and efficiency challenges, David is a leading figure within Healthcare Digital innovation. Recently David secured a ten-year deal with Babylon to introduce cutting-edge Artificial Intelligence (AI) based symptom and video consultations checking across the Trust’s end to end care portfolio.  David has also embedded Public Health into his organisation with Public Health Consultants, Data Scientists, and Epidemiologists to utilise perhaps the richest data set in the NHS comprising of live primary, secondary and community data. This enables proactive management of complex multi-morbid patients before they arrive in an NHS setting.  The use of highly Structured Clinical Data (SCDU) and combining it with clinical judgement for large patient cohorts for direct patient care is recognised as a leading innovation in the NHS.